T +86 21 6132 5900
Jiong Deng is a counsel in the Firm's Shanghai office. His practice encompasses a broad range of business transactions and corporate finance transactions relating to China. He concentrates on advising multinational clients on their direct investment projects, acquisitions and restructuring matters as well as on general operations and compliance in China. He also advises Chinese private and state-owned companies in their outbound investments, acquisitions and other business activities and transactions.
Clariant, a Switzerland-based specialty chemicals company, in the establishment of a 50/50 joint venture with Wilmar, a leading listed agribusiness group headquartered in Singapore, to serve as a global platform for the production and distribution of amines and selected amine derivatives worldwide.
Nestlé Health Science S.A., a subsidiary of Nestlé S.A., on a 50/50 joint venture with Chi-Med group, a pharmaceutical and healthcare group based in China and listed on the London Alternative Investment Market.
China UnionPay, the largest bankcard association in China and a global provider of payment solutions, in its strategic acquisitions in the United States as well as compliance matters in connection with the expansion of its international business.
Publicis Groupe SA in the establishment of joint ventures in China, as well as its acquisition of several Chinese domestic advertising and public relations businesses.
TPV Technology Limited (TPV) in acquiring the IT display and public signage businesses of Royal Philips Electronics.
Building Up an Investor-Friendly Derivative Lawsuit System in China, Harvard Journal of International Law, 46 Harv. Int'l L. J., pp.347–385, Summer 2005